3.9 Editorial Material

Pterygium: what about point of care biomarkers?

Related references

Note: Only part of the references are listed.
Review Ophthalmology

New Technologies in Clinical Trials in Corneal Diseases and Limbal Stem Cell Deficiency: Review from the European Vision Institute Special Interest Focus Group Meeting

Simona L. Schlereth et al.

Summary: The article discussed new technologies for better diagnosing corneal diseases and limbal stem cell deficiency, including unmet needs and achievable new diagnostic technologies in areas such as dry eye, ocular surface inflammation, imaging, corneal neovascularization, and corneal grafting.

OPHTHALMIC RESEARCH (2021)

Article Ophthalmology

Pterygium: pathogenesis, diagnosis and treatment

Alexander C. Rokohl et al.

Summary: Treatment of pterygium involves surgical excision, postoperative use of artificial tears and topical steroids, and long-term UV protection. These methods help prevent recurrence of pterygium.

OPHTHALMOLOGE (2021)

Review Ophthalmology

Mechanisms and biomarker candidates in pterygium development

Ana Claudia Viana Wanzeler et al.

ARQUIVOS BRASILEIROS DE OFTALMOLOGIA (2019)

Article Ophthalmology

Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases

Felix Bock et al.

PROGRESS IN RETINAL AND EYE RESEARCH (2013)

Article Ophthalmology

Antiangiogenic therapy at the ocular surface. When, what and why?

F. Bock et al.

OPHTHALMOLOGE (2011)

Review Ophthalmology

The science of pterygia

J. C. Bradley et al.

BRITISH JOURNAL OF OPHTHALMOLOGY (2010)

Article Ophthalmology

Pterygium - Etiology, clinical aspects and novel adjuvant therapies

L. M. Heindl et al.

OPHTHALMOLOGE (2010)

Review Ophthalmology

Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases

N Di Girolamo et al.

PROGRESS IN RETINAL AND EYE RESEARCH (2004)